{"keywords":["Bile duct cancer","biomarker","cholangiocarcinoma","diagnosis","prognosis","serum"],"meshTags":["Bile Duct Neoplasms","CA-19-9 Antigen","Carcinoembryonic Antigen","Humans","Mucins"],"meshMinor":["Bile Duct Neoplasms","CA-19-9 Antigen","Carcinoembryonic Antigen","Humans","Mucins"],"publicationTypes":["Journal Article","Review"],"abstract":"Bile duct cancer (BDC) is a disease with a very grave prognosis, often diagnosed too late.\nThe aim of this review is to evaluate available literature on tumor markers in serum from patients with BDC.\nUsing the search words \"serum markers\", \"bile duct cancer\", \"cholangiocarcinoma\", \"biomarker\" and \"tumor marker\", a search was carried out.\nSeventy-five studies were included in the review.\nCA19-9 is by far the most studied and most promising diagnostic and/or prognostic marker in BDC. But also the different mucins are interesting as new markers of BDC in serum.","title":"Serum tumor markers in bile duct cancer--a review.","pubmedId":"24857368"}